Navigation Links
ConvaTec Announces 2014 Second Quarter Earnings Call
Date:8/14/2014

LUXEMBOURG, Aug. 14, 2014 /PRNewswire/ -- ConvaTec today announced that it will hold an analyst and investor call to discuss 2014 second quarter results on Tuesday, August 19, 2014. Ken Berger, CEO, and Nigel Clerkin, CFO, will host the call at 9:00 AM ET live via telephone.

To participate in the conference call within the U.S. and Canada, dial (877) 366-0267.

To participate in the conference call outside the U.S. and Canada, dial (760) 666-3086.

The conference ID is 88736401.

Participants should dial in 10 minutes prior to the start of the call. The Company's 2014 Second Quarter Report will be available on the Company's website prior to the call under the Investors tab at www.convateccorporate.com.

For more information, please contact investorrelations@convatec.com.

About ConvaTec
ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners. More information is available at www.convatec.com.

Contacts

Investor Relations:
Robert McKee
Senior Vice President
ConvaTec
336-547-3701
investorrelations@convatec.com

Media Relations:
Punnie Donohue
Director
ConvaTec
336-297-3087
mediarelations@convatec.com


'/>"/>
SOURCE ConvaTec
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Announces 2013 Journal Impact Factor Highlights
2. Cardium Announces Review in Journal Of Cardiovascular Pharmacology Finds Gene Therapy For Subset Of Heart Disease Patients Highly Warranted
3. NORD Announces Agenda for 2014 Rare Diseases and Orphan Products Breakthrough Summit
4. Whitehouse Laboratories Announces Participation at 13th Annual Contract Pharma Conference
5. FutureCeuticals Announces Publication of Human Clinical Study on ability of a dietary supplement ingredient to inhibit free radical production in vivo
6. BioNano Genomics Announces The Purchase Of The Irys System By The Wellcome Trust Sanger Institute
7. FlexTech Alliance Announces 2015FLEX Conference Theme, Call for Papers and Advisory Committee
8. Fertility Associates of Memphis Announces New Physician
9. Regado Biosciences Announces Second Quarter 2014 Financial Results and Corporate Highlights
10. OXIS International announces plans to Enter the Cannabis Biotech Sector, Completion of Financing, Changes to the Board of Directors
11. Braskem announces 2Q14 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... ... is has acquired Kendall Research Systems, LLC (KRS) clinical development program. ... develops neural interface technology for research and clinical applications. The terms of the ...
(Date:2/22/2017)... 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today its ... the Annual Biocom Global Life Science Partnering Conference.  The ... AM, at the Torrey Pines Lodge, in San Diego.  ... at Biocom who have chosen our company, amongst numerous ... companies, investors, and clinical researchers," said Mr. Chen. "In ...
(Date:2/22/2017)... (PRWEB) , ... February 22, ... ... Collaborative (TOPEC), the leading medical education provider of women’s health, primary ... by the Accreditation Council for Continuing Medical Education (ACCME). ACCME’s Accreditation with ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... engineers, and scientists from around the world, is pleased to announce the 2nd ... and 23, 2017. This premier, online-only conference focused on the development and advancements ...
Breaking Biology Technology:
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
Breaking Biology News(10 mins):